DD269148A5 - Verfahren zur herstellung von 5-amino-4-hydroxy-valeriansaeure-derivaten - Google Patents

Verfahren zur herstellung von 5-amino-4-hydroxy-valeriansaeure-derivaten Download PDF

Info

Publication number
DD269148A5
DD269148A5 DD87305909A DD30590987A DD269148A5 DD 269148 A5 DD269148 A5 DD 269148A5 DD 87305909 A DD87305909 A DD 87305909A DD 30590987 A DD30590987 A DD 30590987A DD 269148 A5 DD269148 A5 DD 269148A5
Authority
DD
German Democratic Republic
Prior art keywords
lower alkyl
formula
acid
cycloalkyl
amino
Prior art date
Application number
DD87305909A
Other languages
German (de)
English (en)
Inventor
Peter Herold
Christof Angst
Original Assignee
���@����������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ���@����������@��k�� filed Critical ���@����������@��k��
Publication of DD269148A5 publication Critical patent/DD269148A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03Monocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/26Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD87305909A 1986-08-13 1987-08-11 Verfahren zur herstellung von 5-amino-4-hydroxy-valeriansaeure-derivaten DD269148A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH324886 1986-08-13

Publications (1)

Publication Number Publication Date
DD269148A5 true DD269148A5 (de) 1989-06-21

Family

ID=4251859

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87305909A DD269148A5 (de) 1986-08-13 1987-08-11 Verfahren zur herstellung von 5-amino-4-hydroxy-valeriansaeure-derivaten

Country Status (14)

Country Link
US (2) US4898977A (fr)
EP (1) EP0258183B1 (fr)
JP (1) JP2571230B2 (fr)
KR (1) KR950013635B1 (fr)
AT (1) ATE86971T1 (fr)
DD (1) DD269148A5 (fr)
DE (1) DE3784812D1 (fr)
DK (1) DK420887A (fr)
ES (1) ES2053582T3 (fr)
FI (1) FI90762C (fr)
HU (3) HU200981B (fr)
IL (1) IL83497A (fr)
MX (1) MX7727A (fr)
PT (1) PT85520B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992562A (en) * 1985-08-09 1991-02-12 Pfizer Inc. Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
US5076973A (en) * 1988-10-24 1991-12-31 Arizona Board Of Regents Synthesis of dolastatin 3
AU629867B2 (en) * 1988-11-17 1992-10-15 Imperial Chemical Industries Plc Triazolo (4,3a) pyrazine derivatives
GB8912659D0 (en) * 1989-06-02 1989-07-19 Ici Plc Process
GB8927915D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Novel alcohols
DE4008403A1 (de) * 1990-03-16 1991-09-19 Merck Patent Gmbh Glykolsaeurederivate
US5436339A (en) * 1991-03-06 1995-07-25 Abbott Laboratories Process for the preparation of a substituted diaminoalcohol
EP0546230A1 (fr) * 1991-12-10 1993-06-16 Merrell Dow Pharmaceuticals Inc. Nouveau procédé pour la préparation de l'acide 4-amino 5-hexénoique
US5294737A (en) * 1992-02-27 1994-03-15 The Research Foundation State University Of New York Process for the production of chiral hydroxy-β-lactams and hydroxyamino acids derived therefrom
AU688403B2 (en) * 1993-11-03 1998-03-12 Commonwealth Scientific And Industrial Research Organisation Allylic chain transfer agents
US5977278A (en) * 1993-11-03 1999-11-02 E. I. Du Pont De Nemours And Company Polymers formed from allylic chain transfer agents
IL111484A (en) * 1993-11-03 2001-06-14 Commw Scient Ind Res Org Polymerization process using pendant chain transfer means to regulate the molecular weight, the polymers thus obtained and a number of new pesticide compounds
US5475138A (en) * 1994-07-07 1995-12-12 Pharm-Eco Laboratories Incorporated Method preparing amino acid-derived diaminopropanols
US5473104A (en) * 1994-09-13 1995-12-05 Neurocrine Biosciences, Inc. Process for the preparation of L-carnitine
US5760019A (en) * 1996-07-12 1998-06-02 The Research Foundation Of State University Of New York Silanol enzyme inhibitors
US6423850B1 (en) 1999-06-18 2002-07-23 E.I. Du Pont De Nemours And Company Preparation and use of gamma-butyrolactones as cross-linking agents
US6833460B2 (en) * 1999-06-18 2004-12-21 E. I. Du Pont De Nemours And Company Preparation and use of gamma-butyrolactones as cross-linking agents
US7314953B2 (en) * 2001-03-27 2008-01-01 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) * 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) * 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
EP1511477A4 (fr) * 2002-05-22 2008-04-09 Errant Gene Therapeutics Llc Inhibiteurs d'histone desacetylase bases sur des composes alpha-ceto-epoxydes
US20060160902A1 (en) * 2004-11-08 2006-07-20 Wiech Norbert L Histone deacetylase inhibitors
CN101160281A (zh) * 2005-04-06 2008-04-09 特瓦制药工业有限公司 结晶形态的普瑞巴林
US7488846B2 (en) * 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
EP1768950A2 (fr) * 2005-04-11 2007-04-04 Teva Pharmaceutical Industries Ltd. Procede de fabrication de (s)-pregabaline
DE602006017995D1 (de) * 2005-05-10 2010-12-16 Teva Pharma Verfahren zur herstellung von pregabalin und salzen daraus
WO2006122255A1 (fr) * 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Pregabaline exempte d'acide isobutylglutarique et son procede de preparation
US20070043241A1 (en) * 2005-05-10 2007-02-22 Lilach Hedvati Optical resolution of 3-carbamoylmethyl-5-methylhexanoic acid
ES2398579T3 (es) * 2005-09-19 2013-03-20 Teva Pharmaceutical Industries Ltd Una síntesis asimétrica de ácido (S)-(+)-3-(aminometil)-5-metilhexanoico
WO2007139933A2 (fr) * 2006-05-24 2007-12-06 Teva Pharmaceutical Industries Ltd. Procédés pour la préparation d'acide r-(+)-3-(carbamoyl méthyl)-5-méthylhexanoïque et de sels de celui-ci
EP1912931A2 (fr) * 2006-05-31 2008-04-23 Teva Pharmaceutical Industries Ltd. Préparation de (s)-prégabaline nitrile
US20080026433A1 (en) * 2006-05-31 2008-01-31 Lilach Hedvati Use of enzymatic resolution for the preparation of intermediates of pregabalin
KR101036536B1 (ko) * 2007-03-22 2011-05-24 테바 파마슈티컬 인더스트리즈 리미티드 (s)-(+)-3-(아미노메틸)-5-메틸 헥산산의 합성
DE102007049039A1 (de) 2007-10-11 2009-04-16 Reuter Chemischer Apparatebau Kg Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung
EP2297090A1 (fr) * 2008-06-23 2011-03-23 Teva Pharmaceutical Industries Ltd. Synthèse enzymatique stéréosélective de l ester (s) ou (r)-isobutylglutarique
US8257462B2 (en) * 2009-10-15 2012-09-04 Federal-Mogul Corporation Iron-based sintered powder metal for wear resistant applications
JP5585172B2 (ja) * 2010-04-05 2014-09-10 三菱瓦斯化学株式会社 脂環式エステル化合物の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB960005A (en) * 1961-01-18 1964-06-10 Distillers Co Yeast Ltd Production of acrylic and methacrylic esters
DE1914380A1 (de) * 1969-03-21 1970-10-01 Basf Ag Verfahren zur Herstellung von Buta-1,3-dien-1-carbonsaeurealkylestern
US4031115A (en) * 1976-03-29 1977-06-21 Chevron Research Company 4-Pentenoic acid conversion
CH634815A5 (fr) * 1978-08-30 1983-02-28 Firmenich & Cie Procede pour la preparation d'esters et acides gamma, delta-insatures.
US4372974A (en) * 1980-06-25 1983-02-08 New York University Anticonvulsive compositions and method of treating convulsive disorders
US4609643A (en) * 1980-08-06 1986-09-02 Aktiebolaget Hassle Renin inhibitors, treatments and dipeptide synthesis
US4487963A (en) * 1983-01-03 1984-12-11 Merck & Co., Inc. Enantioselective synthesis of 4-amino-3-hydroxy-2,4-(disubstituted)pentanoic acid
US4613676A (en) * 1983-11-23 1986-09-23 Ciba-Geigy Corporation Substituted 5-amino-4-hydroxyvaleryl derivatives
DK356085A (da) * 1984-08-06 1986-02-07 Upjohn Co Reninhaemmende peptid eller et farmaceutisk acceptabelt syreadditionssalt deraf
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives
US4665055A (en) * 1985-06-17 1987-05-12 Merck & Co., Inc. Peptide renin inhibitors
HU204285B (en) * 1986-10-31 1991-12-30 Pfizer Process for producing renin-inhibiting polypeptides of small molecule mass and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK420887A (da) 1988-02-14
KR880002808A (ko) 1988-05-11
ATE86971T1 (de) 1993-04-15
US5010189A (en) 1991-04-23
DE3784812D1 (de) 1993-04-22
JP2571230B2 (ja) 1997-01-16
EP0258183A3 (en) 1989-07-26
JPS6357561A (ja) 1988-03-12
PT85520A (en) 1987-09-01
IL83497A (en) 1993-02-21
HUT44478A (en) 1988-03-28
FI873467A7 (fi) 1988-02-14
EP0258183A2 (fr) 1988-03-02
PT85520B (pt) 1990-06-29
HU198445B (en) 1989-10-30
HU200981B (en) 1990-09-28
MX7727A (es) 1993-12-01
ES2053582T3 (es) 1994-08-01
FI90762B (fi) 1993-12-15
KR950013635B1 (ko) 1995-11-13
EP0258183B1 (fr) 1993-03-17
IL83497A0 (en) 1988-01-31
FI90762C (fi) 1994-03-25
DK420887D0 (da) 1987-08-12
FI873467A0 (fi) 1987-08-10
US4898977A (en) 1990-02-06
HU202218B (en) 1991-02-28

Similar Documents

Publication Publication Date Title
DD269148A5 (de) Verfahren zur herstellung von 5-amino-4-hydroxy-valeriansaeure-derivaten
EP0184550B1 (fr) Dérivés de 5-amino-4-hydroxy valérylamides
Evans et al. A stereocontrolled synthesis of hydroxyethylene dipeptide isosteres using novel, chiral aminoalkyl epoxides and. gamma.-(aminoalkyl)-. gamma.-lactones
EP0400290A1 (fr) Dérivés de l'acide 5-amino-4-hydroxyvalérique utilisables en tant qu'intermédiaires dans la synthèse d'inhibiteurs de la rénine
EP0236734A2 (fr) Dérivés d'amino-5-hydroxy-4-valeryl substitués par des groupes contenant du soufre
DE69503904T2 (de) Phosphinsaeurederivate mit metallopeptidase inhibtorischer wirkung
EP0374098A2 (fr) Inhibiteurs de protéase rétrovirale
EP0271795A2 (fr) Dérivés de l'octahydro-10-oxo-6H-pyridazo[1,2-a][112]diazépine, intermédiaires et procédé pour leur préparation ainsi que médicament les contenant
EP0144290A2 (fr) Dérivés éthylènediamine substitués
DE60131733T2 (de) Verfahren zur herstellung von (2s,3r,4s)-4-hydroxyisoleucin und analoga
AT390619B (de) Verfahren zur herstellung von neuen prolinderivaten
CH628900A5 (fr) Procede de preparation de thio-oximes derivees de cephalosporines et de penicillines.
DE3825242A1 (de) Durch schwefelhaltige gruppen substituierte histidinylamino-verbindungen
EP0271443B1 (fr) Urées N,N'-disubstituées et procédé pour leur préparation
EP0000500B1 (fr) Dérivés de, cephalosporine leur préparation et leurs compositions pharmaceutiques
EP0109362A1 (fr) Composés hétérocycliques, procédé pour leur préparation, compositions pharmaceutiques les contenant et leur application
DE69503905T2 (de) Peptidderivate mit metallopeptidasehemmender aktivität
EP0346281B1 (fr) Dérivés d'acide hydroxamique carbamoylé et procédé pour leur préparation
DE69614508T2 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
DE3431980A1 (de) Aminomethyl-verbindungen
DE69626846T2 (de) Phosphonsäurederivate mit metallopeptidase inhibierender aktivität
SI8810285A (sl) Postopek za pripravo derivatov 5-amino-4-hidroksi-valerianove kisline
DE3725137A1 (de) Neue peptide und peptidderivate, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE3222779A1 (de) Prolinderivate und verfahren zu deren herstellung
DD280764A5 (de) Verfahren zur herstellung von peptid-immunistimulantien

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee